These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31816436)

  • 1. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
    Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
    Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
    Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
    Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
    Tan RZH; Lockart I; Abdel Shaheed C; Danta M
    Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
    Hwang IC; Chang J; Kim K; Park SM
    Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
    Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
    Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies.
    Liu Y; Ren T; Xu X; Jin J
    Eur J Cancer Prev; 2022 Jan; 31(1):35-43. PubMed ID: 33470689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Association of Coffee with Liver Cancer Development: An Updated Systematic Review and Meta-analysis.
    Bhurwal A; Rattan P; Yoshitake S; Pioppo L; Reja D; Dellatore P; Rustgi V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):421-428. PubMed ID: 32830818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
    Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
    JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
    Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
    J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
    Carrat F
    Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
    Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
    Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
    J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
    Liao YH; Hsu RJ; Wang TH; Wu CT; Huang SY; Hsu CY; Su YC; Hsu WL; Liu DW
    BMC Gastroenterol; 2020 Jan; 20(1):6. PubMed ID: 31918672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
    Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
    Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
    Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin in Patients with Viral Hepatitis: Systematic Review and Meta-Analysis of Observational Studies.
    Bian W; Bian W; Li Q; Li Y
    J Gastrointest Cancer; 2024 Jun; 55(2):638-651. PubMed ID: 38557825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
    Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
    BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.
    Bhagavathula AS; Woolf B; Rahmani J; Vidyasagar K; Tesfaye W
    Eur J Clin Pharmacol; 2022 Apr; 78(4):547-555. PubMed ID: 35039907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.